A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)
Status:
Completed
Trial end date:
2014-11-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to see if adding a new type of medication recently approved to
treat overactive bladder (mirabegron) to an antimuscarinic treatment (solifenacin) would be
more effective in controlling incontinence than when using the antimuscarinic treatment
alone.